NPRBusiness
Bayer reaches Roundup settlement that could cost billions

Bayer has reached a settlement over Roundup that could cost the company billions. The money will go to thousands of people who have been or will be diagnosed with non-Hodgkin lymphoma, a blood cancer linked to the herbicide.
This card is an AI-assisted summary of reporting published by NPR. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.